The relation between socioeconomic status and glycemic control in elderly diabetes patients.
Not Applicable
- Conditions
- diabetes
- Registration Number
- JPRN-UMIN000040685
- Lead Sponsor
- Yokohama Hodogaya Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in HbA1c from the start of the study to 6 months later
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link low socioeconomic status to poor glycemic control in elderly type 2 diabetes patients?
How does socioeconomic status affect the efficacy of SGLT2 inhibitors versus GLP-1 agonists in elderly diabetes management?
Which biomarkers correlate with glycemic variability in elderly patients with type 2 diabetes across different socioeconomic groups?
What adverse events are associated with glycemic control disparities in elderly diabetes patients from low-income backgrounds?
How do socioeconomic factors influence the use of combination therapies like metformin and DPP-4 inhibitors in elderly diabetes care?